Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
2021 · Nature Communications · 288 citations
https://doi.org/10.1038/s41467-021-26239-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
2.0K
Citations
24
h-index
33
i10-index
Rhys Jones is an academic researcher from The Fertilizer Institute. The author has contributed to research in topics: Asthma and respiratory diseases & Anesthesia and Pain Management & Anesthesia and Sedative Agents. The author has an h-index of 24, co-authored 62 publications.
ORCID: 0000-0002-5263-9194https://doi.org/10.1038/s41467-021-26239-2
https://doi.org/10.1038/s41598-021-95648-6
Click to start Chat